Welcome to LookChem.com Sign In|Join Free
  • or
1-(4-[(TRIFLUOROMETHYL)SULFANYL]PHENYL)ETHAN-1-AMINE, also known as ET 298, is a chemical compound with the molecular formula C10H11F3NS. It is a trifluoromethylthio-substituted derivative of phenethylamine, characterized by its potential reactivity and toxicity. 1-(4-[(TRIFLUOROMETHYL)SULFANYL]PHENYL)ETHAN-1-AMINE is primarily utilized in the research and development of pharmaceuticals and agrochemicals, serving as a crucial building block for the synthesis of various products.

871519-25-4

Post Buying Request

871519-25-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

871519-25-4 Usage

Uses

Used in Pharmaceutical Industry:
1-(4-[(TRIFLUOROMETHYL)SULFANYL]PHENYL)ETHAN-1-AMINE is used as a building block for the synthesis of various pharmaceuticals. Its unique chemical structure allows for the creation of a wide range of therapeutic agents, contributing to the development of novel treatments for various medical conditions.
Used in Agrochemical Industry:
In the agrochemical industry, 1-(4-[(TRIFLUOROMETHYL)SULFANYL]PHENYL)ETHAN-1-AMINE is employed as a key component in the synthesis of various agrochemicals. Its incorporation into these products enhances their effectiveness in protecting crops from pests and diseases, thereby improving agricultural productivity and crop yield.

Check Digit Verification of cas no

The CAS Registry Mumber 871519-25-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,5,1 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 871519-25:
(8*8)+(7*7)+(6*1)+(5*5)+(4*1)+(3*9)+(2*2)+(1*5)=184
184 % 10 = 4
So 871519-25-4 is a valid CAS Registry Number.

871519-25-4Downstream Products

871519-25-4Relevant academic research and scientific papers

MOF-derived cobalt nanoparticles catalyze a general synthesis of amines

Jagadeesh, Rajenahally V.,Murugesan, Kathiravan,Alshammari, Ahmad S.,Neumann, Helfried,Pohl, Marga-Martina,Radnik, J?rg,Beller, Matthias

, p. 326 - 332 (2017/09/28)

The development of base metal catalysts for the synthesis of pharmaceutically relevant compounds remains an important goal of chemical research. Here, we report that cobalt nanoparticles encapsulated by a graphitic shell are broadly effective reductive amination catalysts. Their convenient and practical preparation entailed template assembly of cobaltdiamine- dicarboxylic acid metal organic frameworks on carbon and subsequent pyrolysis under inert atmosphere.The resulting stable and reusable catalysts were active for synthesis of primary, secondary, tertiary, and N-methylamines (more than 140 examples).The reaction couples easily accessible carbonyl compounds (aldehydes and ketones) with ammonia, amines, or nitro compounds, and molecular hydrogen under industrially viable and scalable conditions, offering cost-effective access to numerous amines, amino acid derivatives, and more complex drug targets.

INSECTICIDAL 4-AMINO-THIENO[2,3-D]-PYRIMIDINE COMPOUNDS AND METHODS OF THEIR USE

-

, (2011/02/24)

Insecticidal 4-Amino--thieno[2,3-d]-pyrimidine compounds and methods of their use to control pests that damage plants and crops and parasites that harm animals. The present invention relates to new insecticidal 4-Amino--thieno[2,3-d]-pyrimidine compounds

SUBSTITUTED NICOTINAMIDE COMPOUNDS AND USES THEREOF

-

Page/Page column 11-12, (2009/04/24)

Substituted nicotinamide compounds corresponding to formula I a process for their preparation, pharmaceutical compositions containing these compounds, and the use thereof for the treatment or inhibition conditions such as pain, epilepsy, migraine, anxiety states, or urinary incontinence.

HYDROXAMATES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS

-

Page/Page column 27-28, (2010/02/15)

Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufac

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 871519-25-4